Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

The United Kingdom medicines authority approved the Alzheimer’s disease drug Kisunla (donanemab) last week for certain patients. This follows the Unites States Food and Drug Administration ...

Conventional dementia medications are designed to relieve symptoms by activating certain operations in the nervous system. Lecanemab, on the other hand, is designed to slow the development of ...

The health ministry approved a medication that helps slow progression of Alzheimer’s disease in the early stages, meaning the drug will become commercially available as early as the end of the year.